Effect of Shotblocker in Reducing Intramuscular Injection Pain in Adult Patients
ConditionPatients Above 18 Years
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorYağmur SÜRMELİ
About this trial
This randomized, double-blind study aimed to determine the effect of ShotBlocker on IMI pain in adult patients who received diclofenac sodium and metamizole sodium as IMI in the emergency department. The main question(s) it aims to answer are as follows:
• \[Is there a difference between the pain score averages between the intervention group and the control group after ShotBlocker? Participants \[Participants in both groups are individuals who applied to the emergency department and received IM injections according to the doctor\'s order.\] If there is a comparison group: Researchers will make a comparison with the control group.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients aged 18 and over who speak Turkish,
Who have signed the informed consent form,
Who are admitted to the emergency room for prescription drug use or who are planned to use diclofenac sodium and metamizole sodium as IMI upon the directive of the emergency room physician will constitute.
Disqualifiers
Pregnant women,
Those with psychiatric disorders,
Those with hearing or vision problems,
Those who applied to the red area of the emergency room,
Trial design
Design model
Parallel
Treatments tested in this trial
ShotBlocker
DeviceA randomized study investigating ShotBlocker in painkillers containing different active ingredients could not be found.
Treatment groups
60 Participants
are divided into 2 treatment groupsGroup A: ShotBlockerExperimental treatment 1 intervention
Group B: Control groupNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Visual Analog Scale (VAS)
The Visual Analog Scale (VAS) is used to measure the pain perceived by the person. In this scale, the individual can indicate their own pain by drawing a line, putting a dot, or pointing between the 10 cm (100 mm) section of the ruler where there is no pain (zero) on one end and the most severe pain on the other end. The distance from the point where there is no pain to the point marked by the individual is measured in centimeters and the value found indicates the individual\'s pain intensity. On the VAS scale, 0-44 mm indicates mild pain, 45-74 mm indicates moderate pain, and 75-100 mm reflects severe pain.
Time frame
12 week.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: